Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
Genetic substudy shows fewer major cardiovascular events with ticagrelor (brilinta) regardless of relevant genetic variability in ACS patients
-
AstraZeneca Announces Agreements in Principle in Seroquel Product Liability Litigation
-
FDA Advisory Committee recommends US FDA approval of Brilinta (ticagrelor) for Acute Coronary Syndromes
-
AstraZeneca Second Quarter and Half Year Results 2010
-
AstraZeneca PLC Appoints New Non-Executive Director
-
Advisory Committee Briefing Materials For Brilinta (Ticagrelor) NDA Available On US FDA Web Site
-
AstraZeneca and MRC Technology Form Strategic Alliance in Discovery Research, Utilising Shared Compound Libraries
-
CRESTOR Patent Upheld By US Court
-
AstraZeneca and MMV Join Efforts in the Fight Against Malaria
-
FDA Resets its Decision Date For Motavizumab
Latest articles and press releases
All of our latest press releases and articles are available to explore
